Bethlehem, PA (PRWEB) September 19, 2012
Jonathan Severino, Manager of QE/QC Process Control at B. Braun Medical Inc., will give a presentation on Full-Scope Risk Management for Implantable Devices at the MEDevice Forum, September 19, at the San Diego Convention Center, from 10:50 a.m. – 11:30 a.m.
As part of the “Design of Implantable Devices” product conference, Severino will offer a requirements update and tactics to enhance design and mitigate safety concerns regarding implantable devices. Topics addressed during the session will include:
- Risk management for implantable devices: the risk management lifecycle
- Integrating risk management into quality systems and design controls
- International quality standard ISO 14971
The MEDevice Forum series and supplier showcase, September 19-20 in Hall F of the convention center, provides a unique setting for in-depth meetings and valuable business opportunities and networking. The Design of Implantable Devices conference is the only conference program in North America to take a full-scope view of the design of implantable medical devices.
On the exhibit floor, B. Braun OEM Division (Booth 313) will promote its contract manufacturing and product capabilities including fluid administration and management products, valves, admixture devices, interventional accessories, catheters and custom kits.
For more information, contact the B. Braun OEM Division toll free at 866-8-BBRAUN or visit http://www.bbraunoem.com.
About B. Braun OEM Division
B. Braun OEM Division delivers complete contract manufacturing capabilities focusing on fluid administration and admixture products, kits, valves, catheters and interventional accessories. OEM takes customers’ designs from the earliest stages through design prototyping, assembly, packaging and sterilization. The B. Braun OEM Division of B. Braun Medical Inc. is based in Bethlehem, Pa.
About B. Braun
Since the early 19th Century, B. Braun has met a myriad of challenges in modern medical therapy with meaningful and trusted solutions. The B. Braun group of companies, including B. Braun, Aesculap® and Central Admixture Pharmacy Services, Inc. (CAPS®), represent thousands of innovations in acute pain management and infusion therapy that are intended to improve care and lower costs while reducing risks to patients and workers. Guided by the company’s “Sharing Expertise®” philosophy, B. Braun works with motivated partners and customers to address the critical issues of infection prevention, medication safety and environmental responsibility.
The B. Braun corporate mission to bring solutions that lead to better patient care have earned the company dozens of awards, certifications and recognitions for innovative products, employment practices, “green” initiatives and community responsibility throughout the world. Consistently recognized by Frost & Sullivan for its medical technology and support services, B. Braun provides professional training through its Aesculap Academy, reaching over 45,000 healthcare professionals each year, teaching best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives. For more information, call 800-227-2862, e-mail us at inquiry(dot)us(at)bbraun(dot)com or visit B. Braun at http://www.bbraunusa.com.